KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoodRx Holdings (GDRX) Non Operating Income (2019 - 2026)

GoodRx Holdings' Non Operating Income history spans 7 years, with the latest figure at -$8.5 million for Q4 2025.

  • On a quarterly basis, Non Operating Income fell 280.64% to -$8.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$14.5 million, a 187.4% decrease, with the full-year FY2025 number at -$31.0 million, down 1063.68% from a year prior.
  • Non Operating Income hit -$8.5 million in Q4 2025 for GoodRx Holdings, down from $694000.0 in the prior quarter.
  • Over the last five years, Non Operating Income for GDRX hit a ceiling of $18.5 million in Q4 2022 and a floor of -$8.5 million in Q4 2025.
  • Historically, Non Operating Income has averaged -$2.2 million across 5 years, with a median of -$5.9 million in 2021.
  • The widest YoY moves for Non Operating Income: up 163.77% in 2021, down 36931.25% in 2021.
  • Tracing GDRX's Non Operating Income over 5 years: stood at $17.7 million in 2021, then increased by 4.46% to $18.5 million in 2022, then plummeted by 144.74% to -$8.3 million in 2023, then soared by 156.83% to $4.7 million in 2024, then plummeted by 280.64% to -$8.5 million in 2025.
  • Business Quant data shows Non Operating Income for GDRX at -$8.5 million in Q4 2025, $694000.0 in Q2 2025, and -$6.7 million in Q1 2025.